Recent insider trading activity from Rasbach Kyle, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Rasbach Kyle | Chief Financial Officer | A | Common Stock | 40875 | $0.00 | 40,875.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Rasbach Kyle | Chief Financial Officer | A | Stock Option (right to buy) | 245250 | $0.00 | 245,250.0000 | 0 | 9999.99% | 0.00% |